The amyloid cascade hypothesis: an updated critical review
Brain · 03.10.2023 · 146 (10) · 3969-3990
DOI: 10.1093/brain/awad159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 15.05.2023. Verfasst von Kasper P Kepp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Biophysical and Biomedicinal chemistry, DTU Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 289-mal zitiert (Crossref) und nennt 450 Literaturangaben. Gefördert von: Boyarsky, Ministry of Health.
Abstract (Originalsprache)
Results from recent clinical trials of antibodies that target amyloid-β (Aβ) for Alzheimer’s disease have created excitement and have been heralded as corroboration of the amyloid cascade hypothesis. However, while Aβ may contribute to disease, genetic, clinical, imaging and biochemical data suggest a more complex aetiology. Here we review the history and weaknesses of the amyloid cascade hypothesis in view of the new evidence obtained from clinical trials of anti-amyloid antibodies. These trials indicate that the treatments have either no or uncertain clinical effect on cognition. Despite the importance of amyloid in the definition of Alzheimer’s disease, we argue that the data point to Aβ playing a minor aetiological role. We also discuss data suggesting that the concerted activity of many pathogenic factors contribute to Alzheimer’s disease and propose that evolving multi-factor disease models will better underpin the search for more effective strategies to treat the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Biophysical and Biomedicinal chemistry, DTU Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Icahn School of Medicine at Mount Sinai Medical Center, New York, NY 10029, USA.
- Department of Nuclear Medicine, Odense University Hospital, 5000 Odense C, Denmark.
- Department of Clinical Research, University of Southern Denmark, 5000 Odense C, Denmark.
- Center for Advanced Studies and Technology-CAST, and Institute for Advanced Biotechnology (ITAB), University G. d'Annunzio of Chieti-Pescara, Chieti, 66013, Italy.
- Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, 66013, Italy.
ORCID-Profile: Kasper P Kepp, Stefano L Sensi
Förderung
- Boyarsky
- Ministry of Health
Zitieren
APA
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023). The amyloid cascade hypothesis: an updated critical review. Brain, 146(10), 3969-3990. https://doi.org/10.1093/brain/awad159
Vancouver
Kepp KP, Robakis NK, Høilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain. 2023;146(10):3969-3990. doi:10.1093/brain/awad159
BibTeX
@article{Kepp2023,
author = {Kepp, Kasper P and Robakis, Nikolaos K and Høilund-Carlsen, Poul F and Sensi, Stefano L and Vissel, Bryce},
title = {The amyloid cascade hypothesis: an updated critical review},
journal = {Brain},
year = {2023},
volume = {146},
number = {10},
pages = {3969--3990},
doi = {10.1093/brain/awad159}
}
EUVIMED